The β2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB-231 Cell Line.

CONCLUSION: Our results suggest that salbutamol could be an effective adjuvant drug for the treatment of metastatic breast cancer. PMID: 28359245 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28359245?dopt=Abstract

Source: Current Cancer Drug Targets - March 30, 2017 Category: Cancer & Oncology Authors: Rivero EM, Piñero CP, Gargiulo L, Entschladen F, Zänker K, Bruzzone A, Lüthy IA Tags: Curr Cancer Drug Targets Source Type: research